Association of clonal hematopoiesis of indeterminate potential with cardiometabolic multimorbidity progression and mortality: a prospective study of UK Biobank
CHIP serves as an independent risk factor for transitioning to the first CMD incidence and for mortality but is not associated with CMM development. CHIP-targeted management may represent a promising strategy for the primary prevention of CMD and for reducing mortality risk.
Authors
- Tianqi Ma (ORCID: https://orcid.org/0000-0002-2919-4764)
- Chenzhe Zuo
- Shujun Yang (ORCID: https://orcid.org/0000-0002-1572-5747)
- Yuanfeng Huang (ORCID: https://orcid.org/0009-0005-0423-8491)
- Jinchen Li (ORCID: https://orcid.org/0000-0001-5522-806X)
- Xunjie Cheng (ORCID: https://orcid.org/0000-0001-8766-0594)
- Yu Tan
- Guogang Zhang (ORCID: https://orcid.org/0000-0001-9191-6011)
- Dihan Fu
- Qunyong Peng (ORCID: https://orcid.org/0009-0001-5682-9403)
Institutions
- Central South University (CN)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-05-24
- DOI
- https://doi.org/10.1186/s40001-025-02639-8
- Citations
- 3
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 5.31
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Hunan Province